nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0564	0.118	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0524	0.11	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0467	0.098	CbGpPWpGaD
Boceprevir—CTSL—forebrain—attention deficit hyperactivity disorder	0.0376	0.0719	CbGeAlD
Boceprevir—CMA1—cardiovascular system—attention deficit hyperactivity disorder	0.0372	0.0711	CbGeAlD
Boceprevir—CTSL—cardiovascular system—attention deficit hyperactivity disorder	0.0318	0.0608	CbGeAlD
Boceprevir—CTSV—midbrain—attention deficit hyperactivity disorder	0.0304	0.0581	CbGeAlD
Boceprevir—CTSV—nervous system—attention deficit hyperactivity disorder	0.025	0.0478	CbGeAlD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.0249	0.0522	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.0249	0.0522	CbGpPWpGaD
Boceprevir—CTSL—midbrain—attention deficit hyperactivity disorder	0.0249	0.0475	CbGeAlD
Boceprevir—CTSS—forebrain—attention deficit hyperactivity disorder	0.0248	0.0475	CbGeAlD
Boceprevir—CTSV—central nervous system—attention deficit hyperactivity disorder	0.0241	0.046	CbGeAlD
Boceprevir—CTSK—cardiovascular system—attention deficit hyperactivity disorder	0.024	0.0458	CbGeAlD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.0231	0.0485	CbGpPWpGaD
Boceprevir—CTSS—cardiovascular system—attention deficit hyperactivity disorder	0.021	0.0401	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.0206	0.0433	CbGpPWpGaD
Boceprevir—CTSL—nervous system—attention deficit hyperactivity disorder	0.0204	0.039	CbGeAlD
Boceprevir—CTSL—central nervous system—attention deficit hyperactivity disorder	0.0197	0.0376	CbGeAlD
Boceprevir—CTSL—cerebellum—attention deficit hyperactivity disorder	0.0192	0.0367	CbGeAlD
Boceprevir—CTSV—brain—attention deficit hyperactivity disorder	0.0191	0.0365	CbGeAlD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.017	0.0356	CbGpPWpGaD
Boceprevir—CTSS—midbrain—attention deficit hyperactivity disorder	0.0164	0.0313	CbGeAlD
Boceprevir—CTSL—brain—attention deficit hyperactivity disorder	0.0156	0.0298	CbGeAlD
Boceprevir—CTSK—nervous system—attention deficit hyperactivity disorder	0.0154	0.0294	CbGeAlD
Boceprevir—CTSK—central nervous system—attention deficit hyperactivity disorder	0.0148	0.0283	CbGeAlD
Boceprevir—CTSK—cerebellum—attention deficit hyperactivity disorder	0.0145	0.0277	CbGeAlD
Boceprevir—CTSS—nervous system—attention deficit hyperactivity disorder	0.0135	0.0258	CbGeAlD
Boceprevir—CTSS—central nervous system—attention deficit hyperactivity disorder	0.013	0.0248	CbGeAlD
Boceprevir—CTSS—cerebellum—attention deficit hyperactivity disorder	0.0127	0.0242	CbGeAlD
Boceprevir—CTSK—brain—attention deficit hyperactivity disorder	0.0118	0.0225	CbGeAlD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—STUB1—attention deficit hyperactivity disorder	0.0118	0.0247	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—STUB1—attention deficit hyperactivity disorder	0.0118	0.0247	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.0104	0.0219	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.0104	0.0219	CbGpPWpGaD
Boceprevir—CTSS—brain—attention deficit hyperactivity disorder	0.0103	0.0197	CbGeAlD
Boceprevir—CMA1—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.00969	0.0203	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.00863	0.0181	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—STUB1—attention deficit hyperactivity disorder	0.00802	0.0168	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.00711	0.0149	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00625	0.0131	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00625	0.0131	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00582	0.0122	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00582	0.0122	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00518	0.0109	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00482	0.0101	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00459	0.00964	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00459	0.00964	CbGpPWpGaD
Boceprevir—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00438	0.00837	CbGeAlD
Boceprevir—CTSS—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00427	0.00896	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00397	0.00833	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.0038	0.00798	CbGpPWpGaD
Boceprevir—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00371	0.00708	CbGeAlD
Boceprevir—CTSL—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00364	0.00765	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00364	0.00765	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STUB1—attention deficit hyperactivity disorder	0.00353	0.00741	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STUB1—attention deficit hyperactivity disorder	0.00353	0.00741	CbGpPWpGaD
Boceprevir—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00336	0.00642	CbGeAlD
Boceprevir—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00324	0.00618	CbGeAlD
Boceprevir—CTSS—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00313	0.00657	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00302	0.00634	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STUB1—attention deficit hyperactivity disorder	0.00292	0.00614	CbGpPWpGaD
Boceprevir—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00289	0.00553	CbGeAlD
Boceprevir—CMA1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00272	0.0057	CbGpPWpGaD
Boceprevir—CTSV—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00267	0.00561	CbGpPWpGaD
Boceprevir—CTSL—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00267	0.00561	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00249	0.00522	CbGpPWpGaD
Boceprevir—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00242	0.00507	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STUB1—attention deficit hyperactivity disorder	0.00241	0.00505	CbGpPWpGaD
Boceprevir—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00238	0.00455	CbGeAlD
Boceprevir—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00229	0.00438	CbGeAlD
Boceprevir—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00224	0.00428	CbGeAlD
Boceprevir—CTSK—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00222	0.00465	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00212	0.00445	CbGpPWpGaD
Boceprevir—CTSS—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00182	0.00383	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00182	0.00382	CbGpPWpGaD
Boceprevir—ABCB1—brain—attention deficit hyperactivity disorder	0.00182	0.00347	CbGeAlD
Boceprevir—CMA1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00178	0.00375	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00175	0.00367	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0016	0.00335	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00124	0.0026	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00108	0.00227	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00101	0.00211	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000974	0.00204	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000957	0.00201	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000945	0.00198	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000933	0.00196	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000933	0.00196	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000881	0.00185	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000854	0.00179	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000848	0.00178	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000842	0.00177	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000795	0.00167	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000773	0.00162	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000759	0.00159	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000742	0.00156	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000637	0.00134	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000617	0.00129	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000595	0.00125	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000568	0.00119	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EP300—attention deficit hyperactivity disorder	0.000544	0.00114	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EP300—attention deficit hyperactivity disorder	0.000544	0.00114	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EP300—attention deficit hyperactivity disorder	0.00045	0.000945	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000397	0.000834	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000394	0.000828	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000392	0.000822	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EP300—attention deficit hyperactivity disorder	0.000371	0.000779	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000349	0.000733	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000327	0.000686	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000277	0.000581	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000264	0.000553	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000254	0.000534	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000241	0.000506	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000241	0.000506	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000237	0.000498	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000221	0.000463	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000193	0.000405	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000183	0.000385	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000182	0.000382	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000182	0.000382	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000179	0.000376	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000166	0.000349	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000162	0.000341	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000146	0.000307	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000145	0.000305	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000145	0.000304	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.000291	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000112	0.000235	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000112	0.000235	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00011	0.000231	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00011	0.000231	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000109	0.00023	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000103	0.000215	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.96e-05	0.000188	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.53e-05	0.000179	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.79e-05	0.000143	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.74e-05	0.000142	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.26e-05	0.000131	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.73e-05	9.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.91e-05	6.11e-05	CbGpPWpGaD
